Xspray Pharma’s long-term incentive program LTI 2022 fully subscribed

Press release 2022-06-09

Xspray Pharma AB (publ) today announces the outcome of the subscription of options in the incentive program approved at the Annual General Meeting on May 19, 2022. The long-term incentive program 2022 (LTI 2022) in the form of warrants and employee stock options was fully subscribed, in total 421,875 options will be issued. All members of the management team subscribed to their respective share of the program.

The strike price amounts to SEK 132.20 per share.

Maximum dilution of the share upon full utilization of the warrants amounts to 2,0 percent based on the current number of shares.